Full Text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Glioblastoma is one of the most common and aggressive forms of brain tumor, a rare disease for which there is a great need for innovative therapies. ONC201, a new drug substance, has been used in a compassionate treatment program where the choice of dosage form and regimen have yet to be justified. The prior knowledge needed to anticipate ONC201 stability problems has recently been partially addressed, by (i) showing that ONC201 is sensitive to light and oxidation and (ii) identifying the molecular structures of the main degradation products formed. The aim of the work presented here was to improve our understanding of the degradation pathways of ONC201 using data from ab initio calculations and experimental work to supplement the structural information we already published. The C–H bonds located αto the amine of the tetrahydropyridine group and those located alpha to the imine function of the dihydroimidazole group exhibit the lowest bond dissociation energies (BDEs) within the ONC201 molecule. Moreover, these values drop well below 90 kcal.mol−1 when ONC201 is in an excited state (S1; T1). The structures of the photoproducts we had previously identified are consistent with these data, showing that they would have resulted from radical processes following the abstraction of alpha hydrogens. Concerning ONC201’s sensitivity to oxidation, the structures of the oxidation products matched the critical points revealed through mapped electrostatic potential (MEP) and average local ionization energy (ALIE). The data obtained from ab initio calculations and experimental work showed that the reactivity of ONC201 to light and oxidation conditions is highly dependent on pH. While an acidic environment (pH < 6) contributes to making ONC201 quantitatively more stable in solution in the face of oxidation and photo-oxidation, it nevertheless seems that certain chemical groups in the molecule are more exposed to nucleophilic attacks, which explains the variation observed in the profile of degradation products formed in the presence of certain antioxidants tested. This information is crucial to better understand the stability results in the presence of antioxidant agents and to determine the right conditions for them to act.

Details

Title
Molecular Mechanisms Involved in the Chemical Instability of ONC201 and Methods to Counter Its Degradation in Solution
Author
Annereau, Maxime 1   VIAFID ORCID Logo  ; Vignes, Marina 1 ; Lucas, Denis 2 ; Rieutord, André 2   VIAFID ORCID Logo  ; Legrand, François-Xavier 3   VIAFID ORCID Logo  ; Rioblanc, François 2 ; Paul, Muriel 4 ; Grill, Jacques 5 ; Philippe-Henri Secretan 6   VIAFID ORCID Logo  ; Do, Bernard 7 

 Université Paris-Saclay, 91400 Orsay, France; [email protected] (M.A.); [email protected] (M.V.); [email protected] (B.D.); Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; [email protected] (L.D.); [email protected] (A.R.); [email protected] (F.R.) 
 Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France; [email protected] (L.D.); [email protected] (A.R.); [email protected] (F.R.) 
 Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France; [email protected] 
 Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Creteil, France; [email protected]; EpidermE, Université Paris Est Creteil, 94000 Creteil, France 
 Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 94800 Villejuif, France; [email protected]; Département de Cancérologie de l’Enfant et de l’Adolescent, Gustave Roussy, Université Paris-Saclay, 94800 Villejuif, France 
 Université Paris-Saclay, Matériaux et Santé, 91400 Orsay, France 
 Université Paris-Saclay, 91400 Orsay, France; [email protected] (M.A.); [email protected] (M.V.); [email protected] (B.D.); Department of Pharmacy, Henri Mondor Hospital, AP-HP, 94000 Creteil, France; [email protected] 
First page
2371
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
19994923
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2882794245
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.